AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
BioMarin Pharmaceuticals Inc
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S76R05
55.95▼ 0.68 (-1.20%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
56.63
Day's Range
55.24 – 56.81
52-Week Range
49.26 – 70.98
Volume
1.6M
Avg Volume
2.3M
Share Statistics
Shares Outstanding
Employees
3,221
Exchange
XNAS
Listed
1999-07-23
Share count as of July 28, 2026

BioMarin Pharmaceuticals Inc (BMRN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about BioMarin Pharmaceuticals Inc (BMRN)
What is BioMarin Pharmaceuticals Inc's Market Cap?
BioMarin Pharmaceuticals Inc's Market Cap is $10.8B, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Enterprise Value?
BioMarin Pharmaceuticals Inc's Enterprise Value is $14.1B, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Trailing P/E?
BioMarin Pharmaceuticals Inc's Trailing P/E is 148.4×, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Price / Sales?
BioMarin Pharmaceuticals Inc's Price / Sales is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's EV / Revenue?
BioMarin Pharmaceuticals Inc's EV / Revenue is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's EV / EBITDA?
BioMarin Pharmaceuticals Inc's EV / EBITDA is 46.8×, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Revenue (TTM)?
BioMarin Pharmaceuticals Inc's Revenue (TTM) is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Net Income (TTM)?
BioMarin Pharmaceuticals Inc's Net Income (TTM) is $73.0M, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's EBITDA?
BioMarin Pharmaceuticals Inc's EBITDA is $302.2M, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Diluted EPS (TTM)?
BioMarin Pharmaceuticals Inc's Diluted EPS (TTM) is 0.38, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BMRNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
REVENUES:
Total revenues
YoY growth+19.9%+2.8%+17.0%+4.1%
OPERATING EXPENSES:
Cost of sales
Research and development
Selling, general and administrative
Intangible asset amortization
Total operating expenses
% of revenue88.8%83.1%105.1%106.0%
INCOME FROM OPERATIONS
% of revenue11.2%16.9%-5.1%-6.0%
Interest income
Interest expense
Other income, net
INCOME BEFORE INCOME TAXES
Provision for income taxes
NET INCOME
% of revenue4.5%13.8%-5.3%-4.0%
EARNINGS PER SHARE, BASIC (in dollars per share)
EARNINGS PER SHARE, DILUTED (in dollars per share)